INSIGHTS ON PHARMACEUTICAL LOGISTICS

• End-To-End Cold Chain Management: A Next-Generation Approach

  Three experts in cold chain management walk through the advantages of end-to-end platforms for bulk drug substance management.

• Friendshoring: A Strategic Shift In Pharma Supply Chains

  To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models.

• Accelerating Cold Chain Expansion: Responding To COVID-19 Challenges

  Review how leveraging cross-functional teamwork helped complete a cold chain infrastructure expansion in a fraction of the expected timeline, ensuring the production of essential COVID-19 therapeutics.

• Windsor Framework: What Is It?

  Learn about the Windsor Framework and how it addresses the challenges of medicine supply chains between the UK and the EU, creating stability and certainty in the post-Brexit world.

• The Post-Pandemic Supply Chain: Improving Resilience Via Value Chains

  11/14/2023

  The COVID-19 pandemic underscored the vulnerability of global supply chains. Explore lessons learned from the pandemic, the concept of supply chain resilience, what to look for in a supplier, and more.

• Scaling For Success: Preparing Your Cell Culture Workflow

  7/21/2025

  Uncover how early planning of medium, feed systems, and manufacturing workflow can mitigate costs, reduce delays, and accelerate therapeutic delivery to patients.

• A Defined Animal Component Free, Protein Free, Salt Base Cryopreservation Solution

  11/27/2024

  NutriFreez D5, a safer cryopreservation solution with reduced DMSO, preserves stem and immune cells effectively. Ongoing research explores non-toxic alternatives to improve cell therapy safety.

• Building A Resilient Supply Chain For Your Next-Generation Peptide Therapeutic

  1/23/2025

  As peptide therapeutics continue to establish themselves as a leading technology for treating chronic indications, drug sponsors must identify reliable peptide building block suppliers to secure high-quality starting materials.

• Risk Mitigation For Late-Stage Clinical Assets

  6/11/2025

  Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.